Back to top
more

CVS Health (CVS)

(Real Time Quote from BATS)

$57.55 USD

57.55
925,499

-1.77 (-2.98%)

Updated Aug 5, 2024 10:12 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (249 out of 251)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

CVS Health (CVS) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

by Zacks Equity Research

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.

CVS Health (CVS) Stock Moves -0.5%: What You Should Know

by Zacks Equity Research

In the most recent trading session, CVS Health (CVS) closed at $60.03, indicating a -0.5% shift from the previous trading day.

Herbalife Ltd (HLF) Tops Q2 Earnings Estimates

by Zacks Equity Research

Herbalife Ltd (HLF) delivered earnings and revenue surprises of 25.58% and 3.17%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate CVS Health (CVS) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Urmimala Biswas headshot

CVS Health (CVS) Stock Pre-Q2 Earnings: To Buy or Not to Buy?

by Urmimala Biswas

CVS Health (CVS) is grappling with a sudden increase in Medicare Advantage members' utilization trend. The Medicaid business, too, is expected to have experienced medical cost pressure in the second quarter.

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

by Zacks Equity Research

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

by Zacks Equity Research

The latest trading day saw CVS Health (CVS) settling at $58.65, representing a +0.19% change from its previous close.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FVD

CVS Health (CVS) Stock Moves -0.57%: What You Should Know

by Zacks Equity Research

The latest trading day saw CVS Health (CVS) settling at $59.57, representing a -0.57% change from its previous close.

CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

In the closing of the recent trading day, CVS Health (CVS) stood at $57.53, denoting a -0.16% change from the preceding trading day.

Urmimala Biswas headshot

CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?

by Urmimala Biswas

While CVS Health (CVS) has been grappling with the pharmacy reimbursement pressure, a turnaround might be in the cards given its several strategic initiatives.

CVS Health (CVS) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, CVS Health (CVS) closed at $59.06, marking a +1.2% move from the previous day.

Kaibalya Pravo Dey headshot

UnitedHealth (UNH) Stock Drops 8% YTD: Should You Hold or Fold?

by Kaibalya Pravo Dey

As commercial business improves within the industry, UnitedHealth (UNH), with its diverse portfolio of offerings, is well-positioned to capitalize on the rising demand.

Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

by Zacks Equity Research

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know

by Zacks Equity Research

CVS Health (CVS) concluded the recent trading session at $61.37, signifying a +0.61% move from its prior day's close.

Andrew Rocco headshot

Bear of the Day: CVS Health (CVS)

by Andrew Rocco

Drugstore giant CVS faces numerous bearish headwinds, which are industry and company-specific. Investors should avoid shares over the next 6-12 months.

Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Netflix and CVS Health have been highlighted as Zacks Bull and Bear of the Day

CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed at $61.03 in the latest trading session, marking a +1.73% move from the prior day.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

by Zacks Equity Research

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Urmimala Biswas headshot

2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry

by Urmimala Biswas

Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.

Why Is CVS Health (CVS) Up 1.6% Since Last Earnings Report?

by Zacks Equity Research

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.